Overview Fluticasone Nasal Spray Patient Preference Study Status: Completed Trial end date: 2006-12-04 Target enrollment: Participant gender: Summary The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration. Phase: Phase 3 Details Lead Sponsor: GlaxoSmithKlineTreatments: FluticasoneXhance